182 related articles for article (PubMed ID: 28110899)
1. Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for
Peters M; Smit Duijzentkunst DA; Westendorp H; van de Pol SMG; Kattevilder R; Schellekens A; van der Voort van Zyp JRN; Moerland MA; van Vulpen M; Hoekstra CJ
Brachytherapy; 2017; 16(2):282-290. PubMed ID: 28110899
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.
Westendorp H; Hoekstra CJ; van't Riet A; Minken AW; Immerzeel JJ
Brachytherapy; 2007; 6(4):231-7. PubMed ID: 17991620
[TBL] [Abstract][Full Text] [Related]
3. Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients.
Westendorp H; Hoekstra CJ; Immerzeel JJ; van de Pol SM; Niël CG; Kattevilder RA; Nuver TT; Minken AW; Moerland MA
Med Phys; 2017 Apr; 44(4):1257-1267. PubMed ID: 28192614
[TBL] [Abstract][Full Text] [Related]
4. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
[TBL] [Abstract][Full Text] [Related]
5. Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.
Golshan M; Mahdavi SS; Samei G; Lobo J; Pickles T; James Morris W; Keyes M; Peacock M; Salcudean SE; Spadinger I
Brachytherapy; 2020; 19(5):589-598. PubMed ID: 32682777
[TBL] [Abstract][Full Text] [Related]
6. A dual modality phantom for cone beam CT and ultrasound image fusion in prostate implant.
Ng A; Beiki-Ardakan A; Tong S; Moseley D; Siewerdsen J; Jaffray D; Yeung IW
Med Phys; 2008 May; 35(5):2062-71. PubMed ID: 18561682
[TBL] [Abstract][Full Text] [Related]
7. Impact of race on biochemical disease recurrence after prostate brachytherapy.
Yamoah K; Stone N; Stock R
Cancer; 2011 Dec; 117(24):5589-600. PubMed ID: 21692058
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate prostate brachytherapy based on registered transrectal ultrasound and in-room cone-beam CT images.
Even AJ; Nuver TT; Westendorp H; Hoekstra CJ; Slump CH; Minken AW
Brachytherapy; 2014; 13(2):128-36. PubMed ID: 24041955
[TBL] [Abstract][Full Text] [Related]
9. Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.
Batchelar D; Gaztañaga M; Schmid M; Araujo C; Bachand F; Crook J
Brachytherapy; 2014; 13(1):75-9. PubMed ID: 24080299
[TBL] [Abstract][Full Text] [Related]
10. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.
Morris WJ; Tyldesley S; Rodda S; Halperin R; Pai H; McKenzie M; Duncan G; Morton G; Hamm J; Murray N
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):275-285. PubMed ID: 28262473
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
12. Comparison between preoperative and real-time intraoperative planning ¹²⁵I permanent prostate brachytherapy: long-term clinical biochemical outcome.
Matzkin H; Chen J; German L; Mabjeesh NJ
Radiat Oncol; 2013 Dec; 8():288. PubMed ID: 24341548
[TBL] [Abstract][Full Text] [Related]
13. Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patients.
Yorozu A; Kuroiwa N; Takahashi A; Toya K; Saito S; Nishiyama T; Yagi Y; Tanaka T; Shiraishi Y; Ohashi T
Brachytherapy; 2015; 14(2):111-7. PubMed ID: 25127123
[TBL] [Abstract][Full Text] [Related]
14. Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
Ellis RJ; Kaminsky DA; Zhou EH; Fu P; Chen WD; Brelin A; Faulhaber PF; Bodner D
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):29-34. PubMed ID: 20961696
[TBL] [Abstract][Full Text] [Related]
15. Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer.
Takamoto A; Tanimoto R; Bekku K; Araki M; Sadahira T; Wada K; Ebara S; Katayama N; Yanai H; Nasu Y
Int J Urol; 2018 May; 25(5):507-512. PubMed ID: 29651796
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis after low-dose-rate prostate brachytherapy with permanent (125)I seed implant: clinical and dosimetric results in 70 patients.
Chiumento C; Montagna A; Clemente S; Cozzolino M; Fusco V
Tumori; 2011; 97(3):335-40. PubMed ID: 21789012
[TBL] [Abstract][Full Text] [Related]
17. Edema and Seed Displacements Affect Intraoperative Permanent Prostate Brachytherapy Dosimetry.
Westendorp H; Nuver TT; Hoekstra CJ; Moerland MA; Minken AW
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):197-205. PubMed ID: 27325474
[TBL] [Abstract][Full Text] [Related]
18. Real-time intraoperative evaluation of implant quality and dose correction during prostate brachytherapy consistently improves target coverage using a novel image fusion and optimization program.
Zelefsky MJ; Cohen GN; Taggar AS; Kollmeier M; McBride S; Mageras G; Zaider M
Pract Radiat Oncol; 2017; 7(5):319-324. PubMed ID: 28377139
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Evaluation of Biochemical Relapse-Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System.
Martell K; Husain S; Taussky D; Angyalfi S; Delouya G; Després P; Beaulieu L; Martin AG; Vigneault E
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):895-903. PubMed ID: 28807532
[TBL] [Abstract][Full Text] [Related]
20. Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy.
da Silva Franca CA; Vieira SL; Carvalho AC; Bernabé AJ; Penna AB
Brachytherapy; 2010; 9(4):307-12. PubMed ID: 20708980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
